These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

328 related items for PubMed ID: 8927716

  • 1. Effects of 60-Hz fields, estradiol and xenoestrogens on human breast cancer cells.
    Dees C, Garrett S, Henley D, Travis C.
    Radiat Res; 1996 Oct; 146(4):444-52. PubMed ID: 8927716
    [Abstract] [Full Text] [Related]

  • 2. DDT mimicks estradiol stimulation of breast cancer cells to enter the cell cycle.
    Dees C, Askari M, Foster JS, Ahamed S, Wimalasena J.
    Mol Carcinog; 1997 Feb; 18(2):107-14. PubMed ID: 9049186
    [Abstract] [Full Text] [Related]

  • 3. Dietary estrogens stimulate human breast cells to enter the cell cycle.
    Dees C, Foster JS, Ahamed S, Wimalasena J.
    Environ Health Perspect; 1997 Apr; 105 Suppl 3(Suppl 3):633-6. PubMed ID: 9168007
    [Abstract] [Full Text] [Related]

  • 4. Synergistic proliferative action of insulin-like growth factor I and 17 beta-estradiol in MCF-7S breast tumor cells.
    Hamelers IH, van Schaik RF, van Teeffelen HA, Sussenbach JS, Steenbergh PH.
    Exp Cell Res; 2002 Feb 01; 273(1):107-17. PubMed ID: 11795951
    [Abstract] [Full Text] [Related]

  • 5. 17beta-Estradiol induces cyclin D1 gene transcription, p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G(1)-arrested human breast cancer cells.
    Altucci L, Addeo R, Cicatiello L, Dauvois S, Parker MG, Truss M, Beato M, Sica V, Bresciani F, Weisz A.
    Oncogene; 1996 Jun 06; 12(11):2315-24. PubMed ID: 8649771
    [Abstract] [Full Text] [Related]

  • 6. Down-regulation of p21WAF1/CIP1 or p27Kip1 abrogates antiestrogen-mediated cell cycle arrest in human breast cancer cells.
    Cariou S, Donovan JC, Flanagan WM, Milic A, Bhattacharya N, Slingerland JM.
    Proc Natl Acad Sci U S A; 2000 Aug 01; 97(16):9042-6. PubMed ID: 10908655
    [Abstract] [Full Text] [Related]

  • 7. Cyclin D2 activates Cdk2 in preference to Cdk4 in human breast epithelial cells.
    Sweeney KJ, Sarcevic B, Sutherland RL, Musgrove EA.
    Oncogene; 1997 Mar 20; 14(11):1329-40. PubMed ID: 9178893
    [Abstract] [Full Text] [Related]

  • 8. CSF-1 activates MAPK-dependent and p53-independent pathways to induce growth arrest of hormone-dependent human breast cancer cells.
    Lee AW, Nambirajan S, Moffat JG.
    Oncogene; 1999 Dec 09; 18(52):7477-94. PubMed ID: 10602507
    [Abstract] [Full Text] [Related]

  • 9. The orphan receptor COUP-TFII regulates G2/M progression of breast cancer cells by modulating the expression/activity of p21(WAF1/CIP1), cyclin D1, and cdk2.
    Nakshatri H, Mendonca MS, Bhat-Nakshatri P, Patel NM, Goulet RJ, Cornetta K.
    Biochem Biophys Res Commun; 2000 Apr 21; 270(3):1144-53. PubMed ID: 10772965
    [Abstract] [Full Text] [Related]

  • 10. Cyclin E-cdk2 activation is associated with cell cycle arrest and inhibition of DNA replication induced by the thymidylate synthase inhibitor Tomudex.
    Yin MB, Guo B, Panadero A, Frank C, Wrzosek C, Slocum HK, Rustum YM.
    Exp Cell Res; 1999 Feb 25; 247(1):189-99. PubMed ID: 10047461
    [Abstract] [Full Text] [Related]

  • 11. Involvement of G1/S cyclins in estrogen-independent proliferation of estrogen receptor-positive breast cancer cells.
    Bindels EM, Lallemand F, Balkenende A, Verwoerd D, Michalides R.
    Oncogene; 2002 Nov 21; 21(53):8158-65. PubMed ID: 12444551
    [Abstract] [Full Text] [Related]

  • 12. Estrogen regulates activity of cyclin-dependent kinases and retinoblastoma protein phosphorylation in breast cancer cells.
    Foster JS, Wimalasena J.
    Mol Endocrinol; 1996 May 21; 10(5):488-98. PubMed ID: 8732680
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
    Coppock DL, Buffolino P, Kopman C, Nathanson L.
    Exp Cell Res; 1995 Nov 21; 221(1):92-102. PubMed ID: 7589260
    [Abstract] [Full Text] [Related]

  • 14. Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53.
    Rao S, Lowe M, Herliczek TW, Keyomarsi K.
    Oncogene; 1998 Nov 05; 17(18):2393-402. PubMed ID: 9811471
    [Abstract] [Full Text] [Related]

  • 15. Flavopiridol induces G1 arrest with inhibition of cyclin-dependent kinase (CDK) 2 and CDK4 in human breast carcinoma cells.
    Carlson BA, Dubay MM, Sausville EA, Brizuela L, Worland PJ.
    Cancer Res; 1996 Jul 01; 56(13):2973-8. PubMed ID: 8674031
    [Abstract] [Full Text] [Related]

  • 16. Insulin/insulin-like growth factor-I and estrogen cooperate to stimulate cyclin E-Cdk2 activation and cell Cycle progression in MCF-7 breast cancer cells through differential regulation of cyclin E and p21(WAF1/Cip1).
    Lai A, Sarcevic B, Prall OW, Sutherland RL.
    J Biol Chem; 2001 Jul 13; 276(28):25823-33. PubMed ID: 11337496
    [Abstract] [Full Text] [Related]

  • 17. Changes in cyclins and cyclin-dependent kinases induced by DNA damaging agents in a human ovarian cancer cell line expressing mutated or wild-type P53.
    Vikhanskaya F, Erba E, D'Incalci M, Broggini M.
    Exp Cell Res; 1996 Sep 15; 227(2):380-5. PubMed ID: 8831577
    [Abstract] [Full Text] [Related]

  • 18. Immunolocalization of cyclins D and E and cyclin dependent kinase (cdk) 2 and 4 in human breast carcinoma.
    Sasano H, Frost AR, Saitoh R, Taniyama Y, Nagura H, Matsunaga G, Takehana K, Kimura M, Silverberg SG.
    Anticancer Res; 1997 Sep 15; 17(5A):3685-90. PubMed ID: 9413224
    [Abstract] [Full Text] [Related]

  • 19. Reduction of Cdc25A contributes to cyclin E1-Cdk2 inhibition at senescence in human mammary epithelial cells.
    Sandhu C, Donovan J, Bhattacharya N, Stampfer M, Worland P, Slingerland J.
    Oncogene; 2000 Nov 09; 19(47):5314-23. PubMed ID: 11103932
    [Abstract] [Full Text] [Related]

  • 20. Modulation of cell cycle control by vitamin D3 and its analogue, EB1089, in human breast cancer cells.
    Wu G, Fan RS, Li W, Ko TC, Brattain MG.
    Oncogene; 1997 Sep 25; 15(13):1555-63. PubMed ID: 9380407
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.